Carisma TherapeuticsCARM
13F holders, Q1 2024 (March 31)51holders
2famous investors
$2.27avg. 13F price*
At the end of Q1 2024, 51 institutions reported holding Carisma Therapeutics Inc. (CARM) in their 13F filings. The largest holders were BlackRock Inc. ($3.9M), Vanguard Group Inc. ($3.6M) and TPG GP A, LLC ($3.3M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Carisma Therapeutics Inc.
- CUSIP
- 14216R101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $199K |
| Exits | 7 | $217K |
Ownership 51 holders
| BlackRock Inc. | 0.00% | Reduce -7.0% | 1,736,368 | $3.9M |
| Vanguard Group Inc. | 0.00% | Add +0.7% | 1,579,961 | $3.6M |
| TPG GP A, LLC | 0.06% | Reduce -13.8% | 1,451,881 | $3.3M |
| Trustees of the University of Pennsylvania | 6.53% | No change | 1,252,107 | $2.8M |
| Geode Capital Management, LLC | 0.00% | Add +2.5% | 528,589 | $1.2M |
| State Street Corp. | 0.00% | Add +5.0% | 525,105 | $1.2M |
| Renaissance Technologies | 0.00% | Add +6.1% | 225,995 | $513K |
| Northern Trust Corp. | 0.00% | Reduce -7.5% | 220,902 | $501K |
| Bridgeway Capital Management, LLC | 0.01% | Reduce -30.9% | 214,884 | $488K |
| Nuveen Asset Management, LLC | 0.00% | No change | 102,702 | $233K |
| Bank of New York Mellon Corp | 0.00% | Reduce -7.0% | 77,712 | $176K |
| Charles Schwab Investment Management Inc. | 0.00% | Reduce -16.2% | 60,952 | $138K |
| Morgan Stanley | 0.00% | Reduce -50.0% | 41,276 | $94K |
| Two Sigma Investments, LP | 0.00% | Add +59.9% | 40,602 | $92K |
| Arrowstreet Capital, Limited Partnership | 0.00% | Reduce -11.7% | 40,605 | $92K |
| Invesco Ltd. | 0.00% | Add +217.4% | 40,409 | $92K |
| Citadel Advisors | 0.00% | New | 38,973 | $88K |
| Rhumbline Advisers | 0.00% | Add +2.1% | 35,088 | $80K |
| UBS Group AG | 0.00% | Reduce -7.7% | 27,203 | $62K |
| Empowered Funds, LLC | 0.00% | Reduce -43.9% | 26,984 | $61K |
| Blodgett Wealth Advisors, LLC | 0.05% | No change | 25,500 | $58K |
| FMR LLC | 0.00% | Reduce -3.0% | 24,013 | $55K |
| Bank of America Corp. | 0.00% | Reduce -50.9% | 21,524 | $49K |
| Wells Fargo & Company | 0.00% | Add +137.3% | 19,371 | $44K |
| Barclays PLC | 0.00% | Reduce -49.0% | 18,670 | $42K |
| CIBC Asset Management Inc | 0.00% | No change | 14,971 | $34K |
| American International Group, Inc. | 0.00% | Reduce -0.8% | 13,140 | $30K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | New | 13,043 | $30K |
| Stratos Wealth Partners, LTD. | 0.00% | New | 12,710 | $29K |
| XTX Topco Ltd | 0.00% | New | 12,540 | $28K |
| Deutsche Bank AG | 0.00% | No change | 12,267 | $28K |
| JPMorgan Chase & Co. | 0.00% | Reduce -33.5% | 11,681 | $27K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +122.8% | 10,287 | $23K |
| Occudo Quantitative Strategies LP | 0.00% | New | 10,120 | $23K |
| Citigroup Inc. | 0.00% | Add +31.0% | 4,999 | $11K |
| California State Teachers Retirement System | 0.00% | Reduce -38.9% | 2,680 | $6K |
| New York State Common Retirement Fund | 0.00% | No change | 2,362 | $5K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 2,202 | $5K |
| Legal & General Group Plc | 0.00% | No change | 2,156 | $5K |
| Group One Trading LLC | 0.00% | Reduce -86.0% | 1,235 | $3K |
| Amalgamated Bank | 0.00% | Reduce -61.4% | 899 | $2K |
| Royal Bank of Canada | 0.00% | Reduce -88.0% | 1,018 | $2K |
| Peoples Bank | 0.00% | No change | 250 | $565 |
| IFP Advisors, Inc | 0.00% | No change | 206 | $467 |
| Osaic Holdings, Inc. | 0.00% | Add +468.0% | 142 | $322 |
| Towne Trust Company, N.A | 0.00% | New | 125 | $284 |
| Ancora Advisors LLC | 0.00% | No change | 65 | $148 |
| National Bank of Canada | 0.00% | No change | 50 | $73 |
| Signature Resources Capital Management, LLC | 0.00% | No change | 14 | $41 |
| Avior Wealth Management, LLC | 0.00% | New | 5 | $11 |
| Cwm, LLC | 0.00% | New | 4 | $0 |
"% of holder's portfolio" is CARM's weight in each manager's 13F, not the share of Carisma Therapeutics Inc. the manager owns.